---
$id: https://graph.org.ai/products/commodity/51161562
$type: Product
source: UNSPSC
code: "51161562"
title: "Norethindrone and ethinyl estradiol combination"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Norethindrone and ethinyl estradiol combination

**UNSPSC Code**: 51161562
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mast cell stabilizer with the molecular structure C11H9NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1M887244YI chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears US NIH Compound Identifier 64753. European Medicines Agency schedules Nivimedone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG. The term NIVIMEDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17). SMILES: CC1=C(C=C2C(=C1)C(=O)C(C2=O)[N+](=O)[O-])C.

